CTNMContineum Therapeutics, Inc.
$13.21+16% 1Y
$13.21
$9.1752 weeks$17.56
Is the price fair?
What CTNM's price assumes
- Price / book
- 1.71
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 1.71
- Market capitalisation
- $494M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry